ESMO Clinical Practice Guidelines: Haematological Malignancies
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Chronic myeloid leukaemia, Newly diagnosed and relapsed mantle cell lymphoma, Multiple myeloma, Newly diagnosed and relapsed follicular lymphoma, Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma, Acute lymphoblastic leukaemia, Peripheral T-cell lymphomas, Diffuse large B cell lymphoma, Chronic lymphocytic leukaemia, Hairy cell leukaemia, Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Myelodysplastic syndromes, Hodgkin's lymphoma, Primary cutaneous lymphoma, Acute myeloblastic leukaemia in adult patients, Waldenstrom's macroglobulinaemia, Gastric marginal zone lymphoma of MALT type.
They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
Haematologic malignancies
Chronic Myeloid Leukaemia: ESMO Clinical Practice Guidelines
Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv41–iv51
Authors: A. Hochhaus, S. Saussele, G. Rosti, F.-X. Mahon, J. J. W. M. Janssen, H. Hjorth-Hansen, J. Richter and C. Buske
Haematologic malignancies
Newly Diagnosed and Relapsed Mantle Cell Lymphoma: ESMO Clinical Practice Guidelines
Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv62–iv71
Authors: M. Dreyling, E. Campo, O. Hermine, M. Jerkeman, S. Le Gouill, S. Rule, O. Shpilberg, J. Walewski and M. Ladetto
Haematologic malignancies
Multiple Myeloma: ESMO Clinical Practice Guidelines
Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv52–iv61.
Authors: P. Moreau, J. San Miguel, P. Sonneveld, M. V. Mateos, E. Zamagni, H. Avet-Loiseau, R. Hajek, M. A. Dimopoulos, H. Ludwig, H. Einsele, S. Zweegman, T. Facon, M. Cavo, E. Terpos, H. Goldschmidt, M. Attal & C. Buske
Haematologic malignancies
Newly Diagnosed and Relapsed Follicular Lymphoma: ESMO Clinical Practice Guidelines
Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v83-v90
Authors: M. Dreyling, M. Ghielmini, S. Rule, G. Salles, U. Vitolo & M. Ladetto
Haematologic malignancies
ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia
Published in 2016 – Ann Oncol 2016; 00: 1–12, 2016
Authors: M. Ladetto, C. Buske, M. Hutchings, M. Dreyling, G. Gaidano, S. Le Gouill, S. Luminari, C. Pott, A. Zamò, E. Zucca and the ESMO Lymphoma Consensus Conference Panel Members
of ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia
Haematologic malignancies
Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma: ESMO Clinical Practice Guidelines
Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v91-v102
Authors: U. Vitolo, J. F. Seymour, M. Martelli, G. Illerhaus, T. Illidge, E. Zucca, E. Campo and M. Ladetto
Haematologic malignancies
Acute Lymphoblastic Leukaemia: ESMO Clinical Practice Guidelines
Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v69-v82
Authors: D. Hoelzer, R. Bassan, H. Dombret, A. Fielding, J. M. Ribera and C. Buske
Haematologic malignancies
Peripheral T-Cell Lymphomas: ESMO Clinical Practice Guidelines
Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v108-v115.
Authors: F. d'Amore, P. Gaulard, L. Trümper, P. Corradini, W.-S. Kim, L. Specht, M. Bjerregaard Pedersen, M. Ladetto
Haematologic malignancies
Diffuse Large B-Cell Lymphoma: ESMO Clinical Practice Guidelines
Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v116-v125.
Authors: H. Tilly, M. Gomes da Silva, U. Vitolo, A. Jack, M. Meignan, A. Lopez-Guillermo, J. Walewski, M. André, P. W. Johnson, M. Pfreundschuh, M. Ladetto
Haematologic malignancies
Chronic Lymphocytic Leukaemia: ESMO Clinical Practice Guidelines
Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v78-v84.
Authors: B. Eichhorst, T. Robak, E. Montserrat, P. Ghia, P. Hillmen, M. Hallek, C. Buske
of Chronic Lymphocytic Leukaemia: ESMO Clinical Practice Guidelines
Haematologic malignancies
Hairy Cell Leukaemia: ESMO Clinical Practice Guidelines
Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v100-v107.
Authors: T. Robak, E. Matutes, D. Catovsky, P.L. Zinzani and C. Buske
Haematologic malignancies
Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms: ESMO Clinical Practice Guidelines
Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v85-v99.
Authors: A. M. Vannucchi, T. Barbui, F. Cervantes, C. Harrison, J.-J. Kiladjian, N. Kröger, J. Thiele and C. Buske
Haematologic malignancies
Myelodysplastic Syndromes: ESMO Clinical Practice Guidelines
Published in 2014 –Ann Oncol (2014) 25 (suppl 3): iii57-iii69.
Authors: P. Fenaux, D. Haase, G. F. Sanz, V. Santini, C. Buske
Haematologic malignancies
Hodgkin's Lymphoma: ESMO Clinical Practice Guidelines
Published in 2014 – Ann Oncol (2014) 25 (suppl 3): iii70-iii75
Authors: D. A. Eichenauer, A. Engert, M. André, M. Federico, T. Illidge, M. Hutchings, M. Ladetto
Haematologic malignancies
Primary Cutaneous Lymphoma: ESMO Clinical Practice Guidelines
Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi149-vi154.
Authors: R. Willemze, E. Hodak, P. L. Zinzani, L. Specht, M. Ladetto